These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 28839258)

  • 41. MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression.
    Chen W; Xu XK; Li JL; Kong KK; Li H; Chen C; He J; Wang F; Li P; Ge XS; Li FC
    Oncotarget; 2017 Apr; 8(14):22783-22799. PubMed ID: 28187000
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular profiling of the tumor microenvironment in glioblastoma patients: correlation of microglia/macrophage polarization state with metalloprotease expression profiles and survival.
    Gjorgjevski M; Hannen R; Carl B; Li Y; Landmann E; Buchholz M; Bartsch JW; Nimsky C
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142630
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypoxia-mediated cancer stem cells in pseudopalisades with activation of hypoxia-inducible factor-1α/Akt axis in glioblastoma.
    Inukai M; Hara A; Yasui Y; Kumabe T; Matsumoto T; Saegusa M
    Hum Pathol; 2015 Oct; 46(10):1496-505. PubMed ID: 26256949
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypoxia-inducible factor-2α (HIF-2α), but not HIF-1α, is essential for hypoxic induction of class III β-tubulin expression in human glioblastoma cells.
    Bordji K; Grandval A; Cuhna-Alves L; Lechapt-Zalcman E; Bernaudin M
    FEBS J; 2014 Dec; 281(23):5220-36. PubMed ID: 25244496
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma.
    Tian T; Mingyi M; Qiu X; Qiu Y
    Oncotarget; 2016 Nov; 7(48):79584-79595. PubMed ID: 27792996
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immune checkpoint molecule herpes virus entry mediator is overexpressed and associated with poor prognosis in human glioblastoma.
    Han MZ; Wang S; Zhao WB; Ni SL; Yang N; Kong Y; Huang B; Chen AJ; Li XG; Wang J; Wang DH
    EBioMedicine; 2019 May; 43():159-170. PubMed ID: 30987862
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Upregulated AHIF-mediated radioresistance in glioblastoma.
    Liao K; Ma X; Chen B; Lu X; Hu Y; Lin Y; Huang R; Qiu Y
    Biochem Biophys Res Commun; 2019 Feb; 509(2):617-623. PubMed ID: 30606477
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LBH589 Inhibits Glioblastoma Growth and Angiogenesis Through Suppression of HIF-1α Expression.
    Yao ZG; Li WH; Hua F; Cheng HX; Zhao MQ; Sun XC; Qin YJ; Li JM
    J Neuropathol Exp Neurol; 2017 Dec; 76(12):1000-1007. PubMed ID: 29136455
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma.
    Bhat KPL; Balasubramaniyan V; Vaillant B; Ezhilarasan R; Hummelink K; Hollingsworth F; Wani K; Heathcock L; James JD; Goodman LD; Conroy S; Long L; Lelic N; Wang S; Gumin J; Raj D; Kodama Y; Raghunathan A; Olar A; Joshi K; Pelloski CE; Heimberger A; Kim SH; Cahill DP; Rao G; Den Dunnen WFA; Boddeke HWGM; Phillips HS; Nakano I; Lang FF; Colman H; Sulman EP; Aldape K
    Cancer Cell; 2013 Sep; 24(3):331-46. PubMed ID: 23993863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypoxia-Driven M2-Polarized Macrophages Facilitate Cancer Aggressiveness and Temozolomide Resistance in Glioblastoma.
    Zhang G; Tao X; Ji B; Gong J
    Oxid Med Cell Longev; 2022; 2022():1614336. PubMed ID: 36046687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma.
    Yang F; Liu X; Liu Y; Liu Y; Zhang C; Wang Z; Jiang T; Wang Y
    Cancer Lett; 2017 Jun; 396():1-9. PubMed ID: 28286260
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.
    Feng X; Szulzewsky F; Yerevanian A; Chen Z; Heinzmann D; Rasmussen RD; Alvarez-Garcia V; Kim Y; Wang B; Tamagno I; Zhou H; Li X; Kettenmann H; Ransohoff RM; Hambardzumyan D
    Oncotarget; 2015 Jun; 6(17):15077-94. PubMed ID: 25987130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction and Assessment of Hypoxia in Glioblastoma Cells In Vitro.
    Gagner JP; Lechpammer M; Zagzag D
    Methods Mol Biol; 2018; 1741():111-123. PubMed ID: 29392695
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanisms operative in the antitumor activity of temozolomide in glioblastoma multiforme.
    Fisher T; Galanti G; Lavie G; Jacob-Hirsch J; Kventsel I; Zeligson S; Winkler R; Simon AJ; Amariglio N; Rechavi G; Toren A
    Cancer J; 2007; 13(5):335-44. PubMed ID: 17921733
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of Hypoxia and the Hypoxic Response in Tumor Xenografts.
    Böğürcü N; Seidel S; Garvalov BK; Acker T
    Methods Mol Biol; 2018; 1742():283-300. PubMed ID: 29330809
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response.
    Besse A; Sana J; Lakomy R; Kren L; Fadrus P; Smrcka M; Hermanova M; Jancalek R; Reguli S; Lipina R; Svoboda M; Slampa P; Slaby O
    Tumour Biol; 2016 Jun; 37(6):7719-27. PubMed ID: 26692101
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma.
    Foltyn M; Luger AL; Lorenz NI; Sauer B; Mittelbronn M; Harter PN; Steinbach JP; Ronellenfitsch MW
    Br J Cancer; 2019 Mar; 120(5):481-487. PubMed ID: 30745581
    [TBL] [Abstract][Full Text] [Related]  

  • 58. c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma.
    Huang M; Liu T; Ma P; Mitteer RA; Zhang Z; Kim HJ; Yeo E; Zhang D; Cai P; Li C; Zhang L; Zhao B; Roccograndi L; O'Rourke DM; Dahmane N; Gong Y; Koumenis C; Fan Y
    J Clin Invest; 2016 May; 126(5):1801-14. PubMed ID: 27043280
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radiogenomic analysis of hypoxia pathway is predictive of overall survival in Glioblastoma.
    Beig N; Patel J; Prasanna P; Hill V; Gupta A; Correa R; Bera K; Singh S; Partovi S; Varadan V; Ahluwalia M; Madabhushi A; Tiwari P
    Sci Rep; 2018 Jan; 8(1):7. PubMed ID: 29311558
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Integrated analysis identified core signal pathways and hypoxic characteristics of human glioblastoma.
    Gao Y; Zhang E; Liu B; Zhou K; He S; Feng L; Wu G; Cao M; Wu H; Cui Y; Zhang X; Liu X; Wang Y; Gao Y; Bian X
    J Cell Mol Med; 2019 Sep; 23(9):6228-6237. PubMed ID: 31282108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.